1. Home
  2. LWAY vs OCGN Comparison

LWAY vs OCGN Comparison

Compare LWAY & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LWAY

Lifeway Foods Inc.

HOLD

Current Price

$24.18

Market Cap

410.6M

ML Signal

HOLD

Logo Ocugen Inc.

OCGN

Ocugen Inc.

HOLD

Current Price

$1.39

Market Cap

492.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LWAY
OCGN
Founded
1986
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
410.6M
492.5M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
LWAY
OCGN
Price
$24.18
$1.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$34.50
$9.75
AVG Volume (30 Days)
84.6K
7.5M
Earning Date
05-14-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
48.33
31.58
EPS
0.30
N/A
Revenue
$103,350,000.00
N/A
Revenue This Year
$16.64
N/A
Revenue Next Year
$17.28
$1,718.38
P/E Ratio
$86.67
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.31
$0.73
52 Week High
$34.20
$2.73

Technical Indicators

Market Signals
Indicator
LWAY
OCGN
Relative Strength Index (RSI) 43.35 34.84
Support Level $23.01 $1.35
Resistance Level $25.37 $1.92
Average True Range (ATR) 1.15 0.09
MACD -0.39 -0.02
Stochastic Oscillator 20.15 1.92

Price Performance

Historical Comparison
LWAY
OCGN

About LWAY Lifeway Foods Inc.

Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: